A daily GLP-1 inhibitor class injection, Victoza remains an important drug ... GLP-1 class thanks to its more patient-friendly weekly dosing schedule. Novo Nordisk has also launched its own ...

Liraglutide, sold under the brand name Victoza for diabetes, is an earlier iteration in the same class as semaglutide, the ...

Victoza offers a second option in these cases, he added. Victoza is Novo Nordisk’s once-daily injectable GLP-1 agonist and made around $3.6 billion in sales last year, making it the top-selling ...